249 related articles for article (PubMed ID: 26179207)
1. The cell cycle regulator 14-3-3σ opposes and reverses cancer metabolic reprogramming.
Phan L; Chou PC; Velazquez-Torres G; Samudio I; Parreno K; Huang Y; Tseng C; Vu T; Gully C; Su CH; Wang E; Chen J; Choi HH; Fuentes-Mattei E; Shin JH; Shiang C; Grabiner B; Blonska M; Skerl S; Shao Y; Cody D; Delacerda J; Kingsley C; Webb D; Carlock C; Zhou Z; Hsieh YC; Lee J; Elliott A; Ramirez M; Bankson J; Hazle J; Wang Y; Li L; Weng S; Rizk N; Wen YY; Lin X; Wang H; Wang H; Zhang A; Xia X; Wu Y; Habra M; Yang W; Pusztai L; Yeung SC; Lee MH
Nat Commun; 2015 Jul; 6():7530. PubMed ID: 26179207
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of 14-3-3σ is predictive of poor prognosis for patients with human uterine papillary serous carcinoma.
Suzuki F; Nagase S; Suzuki K; Oba E; Hiroki E; Matsuda Y; Akahira J; Nishigori H; Sugiyama T; Otsuki T; Yoshinaga K; Takano T; Niikura H; Ito K; Sasano H; Yaegashi N
Tohoku J Exp Med; 2013 Nov; 231(3):193-9. PubMed ID: 24201220
[TBL] [Abstract][Full Text] [Related]
3. 14-3-3σ Contributes to Radioresistance By Regulating DNA Repair and Cell Cycle via PARP1 and CHK2.
Chen Y; Li Z; Dong Z; Beebe J; Yang K; Fu L; Zhang JT
Mol Cancer Res; 2017 Apr; 15(4):418-428. PubMed ID: 28087741
[TBL] [Abstract][Full Text] [Related]
4. 14-3-3sigma exerts tumor-suppressor activity mediated by regulation of COP1 stability.
Su CH; Zhao R; Zhang F; Qu C; Chen B; Feng YH; Phan L; Chen J; Wang H; Wang H; Yeung SC; Lee MH
Cancer Res; 2011 Feb; 71(3):884-94. PubMed ID: 21135113
[TBL] [Abstract][Full Text] [Related]
5. Silencing Filamin A Inhibits the Invasion and Migration of Breast Cancer Cells by Up-regulating 14-3-3σ.
Ji ZM; Yang LL; Ni J; Xu SP; Yang C; Duan P; Lou LP; Ruan QR
Curr Med Sci; 2018 Jun; 38(3):461-466. PubMed ID: 30074213
[TBL] [Abstract][Full Text] [Related]
6. PCNA and JNK1-Stat3 pathways respectively promotes and inhibits diabetes-associated centrosome amplification by targeting at the ROCK1/14-3-3σ complex in human colon cancer HCT116 cells.
Lu YC; Wang P; Wang J; Ma R; Lee SC
J Cell Physiol; 2019 Jul; 234(7):11511-11523. PubMed ID: 30478982
[TBL] [Abstract][Full Text] [Related]
7. 14-3-3σ downregulation suppresses ICC metastasis via impairing migration, invasion, and anoikis resistance of ICC cells.
Yang Z; Jin Q; Hu W; Dai L; Xue Z; Man D; Zhou L; Xie H; Wu J; Zheng S
Cancer Biomark; 2017 Jul; 19(3):313-325. PubMed ID: 28482619
[TBL] [Abstract][Full Text] [Related]
8.
Winter M; Rokavec M; Hermeking H
Cancer Res; 2021 Jul; 81(13):3621-3634. PubMed ID: 34224368
[TBL] [Abstract][Full Text] [Related]
9. Negative cell cycle regulator 14-3-3sigma stabilizes p27 Kip1 by inhibiting the activity of PKB/Akt.
Yang H; Zhang Y; Zhao R; Wen YY; Fournier K; Wu HB; Yang HY; Diaz J; Laronga C; Lee MH
Oncogene; 2006 Aug; 25(33):4585-94. PubMed ID: 16532026
[TBL] [Abstract][Full Text] [Related]
10. Her4 promotes cancer metabolic reprogramming via the c-Myc-dependent signaling axis.
Han J; Zhang Y; Xu J; Zhang T; Wang H; Wang Z; Jiang Y; Zhou L; Yang M; Hua Y; Cai Z
Cancer Lett; 2021 Jan; 496():57-71. PubMed ID: 33038488
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic and proteolytic inactivation of 14-3-3sigma in breast and prostate cancers.
Horie-Inoue K; Inoue S
Semin Cancer Biol; 2006 Jun; 16(3):235-9. PubMed ID: 16682214
[TBL] [Abstract][Full Text] [Related]
12. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
13. Interaction of 14-3-3σ with KCMF1 suppresses the proliferation and colony formation of human colon cancer stem cells.
Zou J; Mi L; Yu XF; Dong J
World J Gastroenterol; 2013 Jun; 19(24):3770-80. PubMed ID: 23840115
[TBL] [Abstract][Full Text] [Related]
14. 14-3-3σ attenuates RhoGDI2-induced cisplatin resistance through activation of Erk and p38 in gastric cancer cells.
Kim IK; Park SM; Cho HJ; Baek KE; Nam IK; Park SH; Ryu KJ; Ryu J; Choi J; Hong SC; Kim JW; Lee CW; Kang SS; Yoo J
Oncotarget; 2013 Nov; 4(11):2045-56. PubMed ID: 24185104
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic changes of TIMP-3, GSTP-1 and 14-3-3 sigma genes as indication of status of chronic inflammation and cancer.
Wang YJ; He L; Yuan M; Tsang WW; Hao L; Wang M; Chow LW; Cheung MN; Liu Q; Ng EL; Loo WT; Chow CY; Bai LJ; Yang Z
Int J Biol Markers; 2014 Sep; 29(3):e208-14. PubMed ID: 25041782
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of the tumor suppressor protein 14-3-3sigma is a sporadic event in cancer of the breast.
Moreira JM; Ohlsson G; Rank FE; Celis JE
Mol Cell Proteomics; 2005 Apr; 4(4):555-69. PubMed ID: 15644556
[TBL] [Abstract][Full Text] [Related]
17. Impact of MYC in regulation of tumor cell metabolism.
Wahlström T; Henriksson MA
Biochim Biophys Acta; 2015 May; 1849(5):563-9. PubMed ID: 25038584
[TBL] [Abstract][Full Text] [Related]
18. Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival.
Baenke F; Dubuis S; Brault C; Weigelt B; Dankworth B; Griffiths B; Jiang M; Mackay A; Saunders B; Spencer-Dene B; Ros S; Stamp G; Reis-Filho JS; Howell M; Zamboni N; Schulze A
J Pathol; 2015 Oct; 237(2):152-65. PubMed ID: 25965974
[TBL] [Abstract][Full Text] [Related]
19. Wig-1 regulates cell cycle arrest and cell death through the p53 targets FAS and 14-3-3σ.
Bersani C; Xu LD; Vilborg A; Lui WO; Wiman KG
Oncogene; 2014 Aug; 33(35):4407-17. PubMed ID: 24469038
[TBL] [Abstract][Full Text] [Related]
20. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer.
Li C; Zhang G; Zhao L; Ma Z; Chen H
World J Surg Oncol; 2016 Jan; 14(1):15. PubMed ID: 26791262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
